Market Overview The cancer biopsy market is molecular as profiling enables precision treatment selection, requiring adequate tissue acquisition for comprehensive genomic analysis that identifies actionable mutations, resistance mechanisms, and clinical trial eligibility. The Cancer Biopsy Market recognizes molecular profiling as treatment-enabling requirement. Current Market Landscape...